Fritextsökning
Innehållstyper
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Lucka 23 - vem finns här?
Varje dag fram till jul får vi här veta vad profiler i life science-världen har på sin önskelista.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Ny vd när Medivir går in i ny fas
I samband med att Medivir genomfört en omorganisation av sin verksamhet kliver Christine Lind in som vd för bolaget.
-
Hey there Summer Eriksson......
.....biomedical analysist at Akademsika sjukhuset in Uppsala. Why are you here at Biotech Forum and Scanlab?
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Ny design på klinstudie
I ett samarbete mellan FDA, NIH och läkemedelsindustrin utvärderas ett flertal behandlingar i samma studie.
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Iddo Leshem tar sig an Norden
Iddo Leshem har börjat sin nya roll som general manager för Bristol-Myers Squibb Norden.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
”Kemipriset till en laddningsbar värld”
Årets pris delas av tre forskare för deras arbete med att utveckla litiumjonbatterier – en av dem är den äldsta nobelpristagaren någonsin.
-
Hon ska styra Atos
Malmöbaserade Atos medical får ny vd när Britt Meelby Jensen nu kliver på medicinteknikbolaget.
-
Nytt nummer ute
I nya numret av Life Science Sweden tittar vi närmare på läkemedelsföretagens miljöarbete och fördjupar oss i flera aspekter av coronaviruset.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.